Literature DB >> 21763201

Inflammatory pathways underlying atrial fibrillation.

Kai Friedrichs1, Anna Klinke, Stephan Baldus.   

Abstract

The pathophysiology of atrial fibrillation (AF) remains incompletely understood, despite its prevalence and contributing role in stroke and heart failure. Whereas previous studies have focused on the electrophysiological characteristics of AF, recent reports shed light on structural remodeling of the atria as a prerequisite for AF. Recent evidence suggests that atrial fibrosis is linked not only to stimulation of myocytes and fibroblasts, but also to the activation state of leukocytes. Recruitment of leukocytes with the release of reactive oxygen species, cytokines and growth factors is followed by increased matrix deposition, which leads to adverse atrial remodeling and suggests that inflammatory pathways are a prerequisite for AF. Here we review current evidence demonstrating the interrelation between inflammation and AF.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21763201     DOI: 10.1016/j.molmed.2011.05.007

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  51 in total

1.  Class I Histone Deacetylase Inhibition for the Treatment of Sustained Atrial Fibrillation.

Authors:  Mitsuru Seki; Ryan LaCanna; Jeffery C Powers; Christine Vrakas; Fang Liu; Remus Berretta; Geena Chacko; John Holten; Pooja Jadiya; Tao Wang; Jeffery S Arkles; Joshua M Copper; Steven R Houser; Jianhe Huang; Vickas V Patel; Fabio A Recchia
Journal:  J Pharmacol Exp Ther       Date:  2016-06-27       Impact factor: 4.030

2.  Circulating fibrosis biomarkers and risk of atrial fibrillation: The Cardiovascular Health Study (CHS).

Authors:  Michael A Rosenberg; Marlena Maziarz; Alex Y Tan; Nicole L Glazer; Susan J Zieman; Jorge R Kizer; Joachim H Ix; Luc Djousse; David S Siscovick; Susan R Heckbert; Kenneth J Mukamal
Journal:  Am Heart J       Date:  2014-02-26       Impact factor: 4.749

3.  Synergistic Research Between the Center of Arrhythmia Research and the Michigan Biology of Cardiovascular Aging at the University of Michigan.

Authors:  Daniel R Goldstein; José Jalife
Journal:  Circ Res       Date:  2017-11-10       Impact factor: 17.367

4.  Low-level transcutaneous electrical vagus nerve stimulation suppresses atrial fibrillation.

Authors:  Stavros Stavrakis; Mary Beth Humphrey; Benjamin J Scherlag; Yanqing Hu; Warren M Jackman; Hiroshi Nakagawa; Deborah Lockwood; Ralph Lazzara; Sunny S Po
Journal:  J Am Coll Cardiol       Date:  2015-03-10       Impact factor: 24.094

5.  Chocolate intake and risk of clinically apparent atrial fibrillation: the Danish Diet, Cancer, and Health Study.

Authors:  Elizabeth Mostofsky; Martin Berg Johansen; Anne Tjønneland; Harpreet S Chahal; Murray A Mittleman; Kim Overvad
Journal:  Heart       Date:  2017-05-23       Impact factor: 5.994

6.  Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease.

Authors:  Nisha Bansal; Dongjie Fan; Chi-yuan Hsu; Juan D Ordonez; Greg M Marcus; Alan S Go
Journal:  Circulation       Date:  2012-12-28       Impact factor: 29.690

7.  Increased pericardial adipose tissue is correlated with atrial fibrillation and left atrial dilatation.

Authors:  Martin Greif; Franz von Ziegler; Reza Wakili; Janine Tittus; Christoph Becker; Susanne Helbig; Ruediger P Laubender; Wolfgang Schwarz; Melvin D'Anastasi; Jan Schenzle; Alexander W Leber; Alexander Becker
Journal:  Clin Res Cardiol       Date:  2013-04-13       Impact factor: 5.460

Review 8.  Sex and Cardiovascular Involvement in Inflammatory Joint Diseases.

Authors:  Santos Castañeda; Carlos González-Juanatey; Miguel A González-Gay
Journal:  Clin Rev Allergy Immunol       Date:  2019-06       Impact factor: 8.667

Review 9.  The immune system in stroke: clinical challenges and their translation to experimental research.

Authors:  Craig J Smith; Catherine B Lawrence; Beatriz Rodriguez-Grande; Krisztina J Kovacs; Jesus M Pradillo; Adam Denes
Journal:  J Neuroimmune Pharmacol       Date:  2013-05-15       Impact factor: 4.147

Review 10.  Evaluating the Atrial Myopathy Underlying Atrial Fibrillation: Identifying the Arrhythmogenic and Thrombogenic Substrate.

Authors:  Jeffrey J Goldberger; Rishi Arora; David Green; Philip Greenland; Daniel C Lee; Donald M Lloyd-Jones; Michael Markl; Jason Ng; Sanjiv J Shah
Journal:  Circulation       Date:  2015-07-28       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.